Oh i hear you and agree, its fun to throw around numbers, but also keep our feet planted as we have ways to go. But its hard to do sometimes, LOL. And no worries, i didnt think you were referring to me, i was just speaking in general....but your numbers are obviously more likely if the yout happens sooner rather than later. I guess thats what it boils down to, at what point exactly will the buyout happen? How much data will there be and how much potential revenue validated by efficacy in trials? Fluid question with fluid and evolving answers, that change a buyout valuation depending on how far along we are. Regardless, i am looking forward to Christmas more this year than ever